KR100801902B1 - Composion for antimutagenic and anticancer containing the extracts of Zizyphus jujube seed - Google Patents
Composion for antimutagenic and anticancer containing the extracts of Zizyphus jujube seed Download PDFInfo
- Publication number
- KR100801902B1 KR100801902B1 KR1020060070374A KR20060070374A KR100801902B1 KR 100801902 B1 KR100801902 B1 KR 100801902B1 KR 1020060070374 A KR1020060070374 A KR 1020060070374A KR 20060070374 A KR20060070374 A KR 20060070374A KR 100801902 B1 KR100801902 B1 KR 100801902B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- jujube seed
- jujube
- antimutagenic
- cancer
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 60
- 230000002790 anti-mutagenic effect Effects 0.000 title claims abstract description 12
- 230000001093 anti-cancer Effects 0.000 title claims description 6
- 241001247821 Ziziphus Species 0.000 title abstract description 52
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 40
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 17
- 201000011510 cancer Diseases 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 239000000401 methanolic extract Substances 0.000 claims description 10
- 206010009944 Colon cancer Diseases 0.000 claims description 7
- 208000029742 colonic neoplasm Diseases 0.000 claims description 5
- 230000002489 hematologic effect Effects 0.000 claims description 3
- 201000007270 liver cancer Diseases 0.000 claims description 2
- 208000014018 liver neoplasm Diseases 0.000 claims description 2
- 240000008866 Ziziphus nummularia Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 13
- 230000003078 antioxidant effect Effects 0.000 abstract description 12
- 239000003963 antioxidant agent Substances 0.000 abstract description 8
- 230000010261 cell growth Effects 0.000 abstract description 4
- 238000011282 treatment Methods 0.000 abstract description 4
- 230000002019 anti-mutation Effects 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract description 2
- 230000005907 cancer growth Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 19
- 230000005764 inhibitory process Effects 0.000 description 9
- 239000003471 mutagenic agent Substances 0.000 description 7
- 231100000707 mutagenic chemical Toxicity 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000004663 cell proliferation Effects 0.000 description 6
- 210000003494 hepatocyte Anatomy 0.000 description 6
- 230000035772 mutation Effects 0.000 description 5
- XKMPRDAFNNEZEM-UHFFFAOYSA-N 8-nitro-1-oxidoquinolin-1-ium Chemical compound C1=C[N+]([O-])=C2C([N+](=O)[O-])=CC=CC2=C1 XKMPRDAFNNEZEM-UHFFFAOYSA-N 0.000 description 4
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- 230000003505 mutagenic effect Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 230000009702 cancer cell proliferation Effects 0.000 description 3
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 239000013043 chemical agent Substances 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 201000005787 hematologic cancer Diseases 0.000 description 2
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 2
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- YHQDZJICGQWFHK-UHFFFAOYSA-N 4-nitroquinoline N-oxide Chemical compound C1=CC=C2C([N+](=O)[O-])=CC=[N+]([O-])C2=C1 YHQDZJICGQWFHK-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102100040653 Tryptophan 2,3-dioxygenase Human genes 0.000 description 1
- 101710136122 Tryptophan 2,3-dioxygenase Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000002038 ethyl acetate fraction Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100000149 liver necrosis Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100001223 noncarcinogenic Toxicity 0.000 description 1
- 230000009701 normal cell proliferation Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
본 발명은 대추씨 추출물을 함유하는 항돌연변이 및 암세포 성장억제 활성 조성물에 관한 것이다. 더욱 상세하게는, 대추씨 물 추출물을 함유하는 돌연변이의 항산화 및 암세포의 성장을 억제하는 효과에 관한 것으로 예방 및 치료용 또는 건강식품의 성분으로서 유용하게 사용할 수 있다. The present invention relates to antimutagenic and cancer cell growth inhibitory active compositions containing jujube seed extract. More specifically, it relates to the antioxidant activity of the mutant containing the jujube seed water extract and the effect of inhibiting the growth of cancer cells, and can be usefully used as a component of prophylaxis and treatment or as a health food.
대추씨 추출물, 항돌연변이, 항산화, 암세포 억제 Jujube seed extract, antimutation, antioxidant, cancer cell suppression
Description
본 발명은 대추씨 추출물을 함유하는 항돌연변이 및 항암활성 조성물에 관한 것이다.The present invention relates to antimutagenic and anticancer active compositions containing jujube seed extract.
현대인들은 과학의 진보와 함께 온갖 식품첨가제가 들어있는 인스턴트 식품 및 가공식품의 섭취로 인하여 매일 자신도 모르는 사이에 유해 성분의 오염으로부터 벗어날 수 없으며, 서구화되어 가는 오늘날 우리의 식생활도 변이원의 섭취는 매우 높다. 이로 인해서 질병의 형태에 있어서도 많은 변화를 가져 왔으며 특히 암을 비롯한 노화와 관련된 성인병의 발병이 증가하고 있다. 현재까지 알려진 발암물질의 85% 이상은 돌연변이원이며 비발암성으로 알려진 10% 이하가 돌연변이원으로 작용하고 있어 발암과 돌연변이간에는 매우 높은 상관관계가 있으며 또한 돌연이변이가 암 유발의 초기단계에서 매우 중요한 작용을 하는 것으로 알려져 있다. 그러므로 돌연변이를 억제할 수 있는 물질은 항발암 작용을 가질 수 있으므로 우리가 일상생활에서 섭취하는 식품으로부터 항변이원성 및 항암성 물질을 탐색하려는 노력이 많이 행해지고 있다. 최근에는 오래전부터 그 약리작용이 알려져 민간요법제로 이용되고 있는 약용식물 및 한약제제를 대상으로 생리활성 물질을 검색하려는 노력이 상당히 괄목할 만한 성과를 보이고 있다. 그 중에서도 대추는 오래전부터 식용 및 각종 약리작용에 의한 민간요법제로 널리 이용되어 왔으며 특히 만성간염, 온몸쇠약, 영양부족 등에 이용되어 왔다. 또한 죽, 차, 떡, 약밥 등의 우리 전통음식에도 많이 이용되어 왔으며 최근에는 대추음료, 액상대추차, 과립대추차, 대추과당, 대추시럽 등의 여러 가공형태로도 이용되고 있다. 최근에는 대추 추출물의 치주질환 항염작용 및 치주 조직재생 효과와 대추 메탄올 추출물이 간세포의 괴사와 효소의 유출을 저해하고 간의 저항력 및 간 기능을 향상시켜 간 보호작용을 가진다는 보고도 있다. 또한 대추 물 추출물의 장내 유산균 증식 및 pH저하 효과, 대추 물 추출물, 에틸아세테이트(ethylacetate) 분획, 암 유발효소인 β-글루쿠로니다아제(β-glucuronidase), 트립토파나아제(tryptophanase)의 높은 저해 효과 및 대장암 억제 효과 등이 보고되었다. 대추 추출물과 관련된 선행특허로서, 대한민국 특허번호 제0583051 “암 치료 및 예방을 위한 계피 및 대추 추출물”에서는 계피 및 대추 추출물을 포함하는 암치료 및 예방용 약학적 조성물 및 기능성 식품에 관한 것으로 각각의 구성성분에 의한 세포 사멸 및 암세포 이동을 억제하는 효과와 구성성분의 혼합에 의해 암세포 성장억제 효과의 상승에 관해 개시한 바 있고, 대한민국 공개번호 제99-0039367 “대추 추출물을 포함하는 혈압 강하용 조성물”에서는 대추 추출물을 포함하여 혈압을 강하시키는 고혈압 치료제 또는 건강식품의 성분에 관해 개시한 바 있다. 이와같이 대추 추출물은 암 또는 고혈압 치료 및 예방 효과가 알려져 있으나 대추씨 추출물을 이용한 연구는 미비한 상태이다.With the advancement of science, modern people can not escape from the pollution of harmful ingredients every day without knowing their own daily consumption of instant foods and processed foods containing all kinds of food additives. Very high. This has led to a number of changes in the form of the disease, especially the increasing incidence of adult diseases related to aging, including cancer. More than 85% of the known carcinogens are mutagens and less than 10% known to be non-carcinogenic are acting as mutagens, so there is a very high correlation between carcinogenesis and mutations, and mutations are very important in the early stages of cancer induction. It is known to work. Therefore, since a substance capable of inhibiting mutations may have an anti-carcinogenic effect, many efforts have been made to search for anti-mutagenic and anti-cancer substances from foods in our daily lives. Recently, efforts to search for bioactive substances in medicinal plants and herbal medicines, which have been known for a long time and have been used as folk remedies, have shown remarkable results. Among them, jujube has been widely used as a folk remedy by edible and various pharmacological effects for a long time, and especially has been used for chronic hepatitis, whole body weakness, lack of nutrition. In addition, it has been used a lot in our traditional foods such as porridge, tea, rice cake, medicinal rice, etc. Recently, it is also used in various processed forms such as jujube drink, liquid jujube tea, granulated jujube tea, jujube fructose, jujube syrup. Recently, the anti-inflammatory and periodontal tissue regeneration effects of jujube extract and the methanol extract of jujube inhibit liver necrosis and enzyme outflow of hepatocytes and improve liver resistance and hepatic function. In addition, the intestinal lactic acid bacteria growth and pH-lowering effect of jujube water extract, jujube water extract, ethylacetate fraction, β-glucuronidase and tryptophanase Inhibitory effects and colorectal cancer inhibitory effects have been reported. As a prior patent related to jujube extract, Korean Patent No. 0583051 “Cinnamon and Jujube Extract for Cancer Treatment and Prevention” relates to a pharmaceutical composition and a functional food for treating and preventing cancer, including cinnamon and jujube extract, respectively. It has been disclosed about the effect of inhibiting cell death and cancer cell migration by components and the increase of cancer cell growth inhibitory effect by mixing the components, Republic of Korea Publication No. 99-0039367 "composition for lowering blood pressure comprising jujube extract" Has disclosed a component of a high blood pressure treatment or health food that lowers blood pressure, including jujube extract. Jujube extract is known to treat and prevent cancer or hypertension, but research using jujube seed extract is incomplete.
본 발명은 상기와 같은 점을 감안하여 안출된 것으로, 대추씨 추출물을 함유하는 항돌연변이와 암세포 성장 억제 예방 및 치료용 조성물을 제공하는데 그 목적이 있다.The present invention has been made in view of the above point, an object of the present invention to provide a composition for preventing and treating anti-mutation and cancer cell growth inhibition containing jujube seed extract.
본 발명의 상기 목적은 대추씨 추출물을 얻은 후 항산화활성 라디칼 소거능을 측정하고 항변이원성을 검사하고 암세포 증식 억제 효과를 측정함으로써 달성하였다. The above object of the present invention was achieved by measuring the antioxidant active radical scavenging ability, antimutagenicity and cancer cell proliferation inhibition after obtaining the jujube seed extract.
이하, 본 발명의 구체적인 구성을 실시예와 실험예를 통하여 상세히 설명한다.Hereinafter, the specific configuration of the present invention will be described in detail through examples and experimental examples.
본 발명은 대추씨의 분말시료를 물 추출물과 에탄올 추출물을 시료로 사용하여 대추씨 추출물의 항산화활성 라디칼 소거능을 측정하는 단계; 항변이원성 검사하는 단계 및 암세포 증식 억제 효과와 정상 간세포 증식 효과를 측정하는 단계로 구성된다.The present invention comprises the steps of measuring the antioxidant active radical scavenging ability of the jujube seed extract using the water extract and ethanol extract as a sample of the powder sample of jujube seed; Anti-mutagenicity and cancer cell proliferation inhibitory effect and normal hepatocyte proliferation effect.
본 발명에서 대추씨 물 추출법 및 메탄올 추출법은 열수추출법을 이용하였 다.Jujube seed water extraction method and methanol extraction method in the present invention was used for hot water extraction.
본 발명에서 대추씨 추출물의 항산화 소거능은 초산 및 항산화활성 용액을 반응시켜 흡광도를 측정하였다.Antioxidant scavenging activity of jujube seed extract in the present invention was measured by absorbing acetic acid and antioxidant active solution.
본 발명에서 대추씨 추출물의 항변이원성 검사는 살모넬라(Salmonella typhimurium) TA100 균주의 돌연변이 유발원인 메틸화학제(N-메틸-N´-니트로-N-니트로소구아니딘; MNNG)와 나이트로놀린옥사이드(4-Nitroquinoline-N-Oxide; 4NQO)의 저해효과로써 확인하였다.Antimutagenicity test of jujube seed extract in the present invention is a methylation agent (N-methyl-N'-nitro-N-nitrosoguanidine; MNNG) and nitronoline oxide (4-) as a mutagen of Salmonella typhimurium TA100 strain. Nitroquinoline-N-Oxide (4NQO) was confirmed as an inhibitory effect.
본 발명에서 대추씨 추출물의 암세포와 정상세포의 증식 효과는 MTT(3-[4,5-dimerthylthiazol-2,5-diphenyl tetrazolium bromide; 이하 MTT) 측정으로 세포독성을 확인하였다.In the present invention, the proliferative effect of cancer cells and normal cells of jujube seed extract was confirmed by cytotoxicity by MTT (3- [4,5-dimerthylthiazol-2,5-diphenyl tetrazolium bromide; MTT) measurement.
실시예1Example 1 : 대추씨의 추출물 조제: Extract preparation of jujube seed
대추씨의 분말시료에 10배의 증류수를 첨가한 후 90~100℃에서 열수 추출하였으며 8시간 동안 3회 반복 추출한 후 여과하였으며 그리고 대추씨의 분말시료에 10배의 99% 메탄올을 첨가한 후 환류 냉각기를 설치한 수욕상에서 8시간 동안 3회 반복 추출한 후 여과하였다. 이 여액들을 감압 농축시켜 물 추출물과 메탄올 추출물로 사용하였다.10 times distilled water was added to the jujube seed powder, followed by hot water extraction at 90-100 ° C., repeated extraction three times for 8 hours, followed by filtration, and 10 times of 99% methanol to the jujube seed powder. After extracting three times for 8 hours in a water bath equipped with a cooler and filtered. The filtrates were concentrated under reduced pressure and used as a water extract and a methanol extract.
실험예1Experimental Example 1 : : DPPHDPPH 라디칼Radical 소거작용 측정 Scavenging Action
대추씨 물 추출물과 메탄올 추출물의 항산화 활성(1,1-diphenyl- 2- picrylhydrazyl; DPPH) 라디칼 소거능은 0.1M의 초산 완충액(pH 5.5)에 시료 및 0.2mM DPPH (1,1-diphenyl-2-picryhydrazyl) 용액을 가하여 10초간 진탕한 후 37℃에서 30분간 반응시킨 다음, 이 반응액을 분광광도계(Spectronic GENESYS 5, MILTON ROY)를 사용하여 517nm에서 흡광도를 측정하였다.Antioxidant activity (1,1-diphenyl-2- picrylhydrazyl; DPPH) radical scavenging activity of jujube seed water extract and methanol extract was measured in 0.1 M acetate buffer (pH 5.5) and 0.2 mM DPPH (1,1-diphenyl-2- After adding picryhydrazyl) and shaking for 10 seconds, the mixture was reacted at 37 ° C for 30 minutes, and then the reaction solution was measured at 517 nm using a spectrophotometer (Spectronic GENESYS 5, MILTON ROY).
실험결과, 표 1과 같이 대추씨 물 추출물에서 0.5mg/mL에서 84%, 0.25mg/mL에서 89%의 높은 항산화 활성을 나타내었으며, 메탄올 추출물에서 1mg/mL에서 91.7%, 0.75mg/mL에서 88.3%의 활성을 나타내었다. 대추씨 물 추출물이 메탄올 추출물에 비하여 높은 항산화활성 소거능을 나타내었다.Experimental results showed that the antioxidant activity of 84% at 0.5mg / mL and 89% at 0.25mg / mL in jujube seed water extract was shown in Table 1, and 91.7% at 1mg / mL and 0.75mg / mL in methanol extract. It showed 88.3% of activity. Jujube seed water extract showed higher antioxidant scavenging activity than methanol extract.
<표 1> 대추씨 물 추출물과 메탄올 추출물의 항산화 활성 소거능<Table 1> Antioxidant Activity Scavenging Activity of Jujube Seed Water Extract and Methanol Extract
실험예2Experimental Example 2 : 항변이원성 검사Antimutagenicity test
대추씨 물 추출물과 메탄올 추출물의 항변이원성 검사는 멸균시킨 튜브(tube)에 시료 50㎕, 돌연변이원 50㎕ , 0.2M 완충액, 대추씨 추출물 자체의 살모넬라(Salmonella typhimurium) TA100 균주 100㎕를 넣고 37℃에서 30분 동안 전처리 배양시켰다. 이것을 평판배지(top agar) 2mL와 혼합한 후 최소평판배 지(minimal glucose agar plates)에 골고루 도말하였다. 37℃에서 48시간 배양한 후 배지 위의 복귀변이주(revertant) 균수를 계수하였다. 한 시료에 대하여 3개의 최소평판배지를 사용하였으며, 변이원에 대한 억제효과는 변이원 물질에 대한 억제율(inhibition rate, %)로 나타내었다. Antimutagenicity test of jujube seed water extract and methanol extract was carried out in a sterile tube with 50 μL of sample, 50 μL of mutagen, 0.2M buffer, Salmonella of jujube seed extract itself. typhimurium ) 100 μl of TA100 strain was added and pre-cultured at 37 ° C. for 30 minutes. This was mixed with 2 mL of top agar and evenly spread on minimal glucose agar plates. After 48 hours of incubation at 37 ° C. the number of revertant strains on the medium was counted. Three minimum plate media were used for one sample, and the inhibitory effect on the mutagen was expressed by the inhibition rate (%) for the mutagen material.
실험결과, 표 2 내지 3에 나타낸 바와 같이 세포내의 DNA에 직접적으로 손상을 주어 돌연변이를 유발하는 물질인 변이 유기체 메틸화학제와 나이트로놀린옥사이드에 대한 대추씨의 물 추출물의 항돌연변이 효과를 살펴본 결과 살모넬라(Salmonella typhimurium) TA100 균주에서 MNNG에 대한 대추씨 물 추출물의 항돌연변이 효과는 물 추출물 10%의 농도에서 75.2% 의 높은 저해효과를 나타내었다. 이러한 결과로 대추씨 물 추출물이 살모넬라(Salmonella typhimurium) TA100 균주에서 MNNG의 돌연변이 억제를 확인할 수 있었다. 또한 4-NQO에 대한 항돌연변이 효과는 시료농도 5%, 2.5%에서 72.2%, 67.2%의 억제효과를 나타내었다. 이상의 결과로 대추씨 물 추출물이 높은 항돌연변이 효과가 있음을 확인하였다. As a result, as shown in Tables 2 to 3, Salmonella showed antimutagenic effects of water extracts of jujube seed on mutant organism methyl chemistry and nitronoline oxide, which are substances that directly induce damage to DNA in cells. ( Salmonella typhimurium ) The antimutagenic effect of jujube seed water extract against MNNG in TA100 strain showed a high inhibitory effect of 75.2% at the concentration of 10% water extract. As a result, the jujube seed water extract is Salmonella typhimurium ) showed inhibition of MNNG mutation in TA100 strain. In addition, the antimutagenic effect on 4-NQO showed an inhibitory effect of 72.2%, 67.2% at 5%, 2.5% of sample concentration. As a result, it was confirmed that the jujube seed water extract had a high antimutagenic effect.
<표 2> 대추씨 물 추출물의 메틸화학제 항돌연변이 효과<Table 2> Antimutagenic Effects of Methyl Chemical Agents from Jujube Seed Water Extracts
실험3Experiment 3 : 암세포 증식 억제 및 정상세포 증식 활성 효과 측정: Inhibition of cancer cell proliferation and measurement of normal cell proliferation activity
세포 증식과 독성을 MTT 측정을 통해 대추씨 추출물이 암세포와 정상세포 성장에 미치는 영향을 살펴보았다. 대추씨 추출물의 인간 간암세포 Hep G2(hepatoma cell, human)와 결장암세포 HT-29(colon carcinoma cell, human), 혈액암세포 U937, 전골수백혈구세포 HL60 및 사람의 정상 간세포 Chang 에서의 증식 억제 효과를 확인하였다. 먼저 배양된 세포에서 배지를 제거한 다음 완충용액을 첨가하여 가볍게 섞은 후 완충용액을 다시 제거하고 0.25% trypsin-EDTA를 첨가하여 37℃에서 5분간 배양하여 세포가 culture dish의 바닥으로부터 완전히 분리되었는지 현미경으로 관찰한 후, 배양배지를 첨가하여 잘 혼합한 다음 세포 수를 1×105cells/mL로 조정하여 실시하였다. 한편 시료는 각각 적당한 농도로 DMSO (dimethysulfoxide)에 용해시켜 0.22㎛ 멤브레인 필터(membrane filter)로 여과한 후 사용하였다. 96-well plate에 준비된 각 세포들을 198㎕씩 분주한 후 37℃, 5% CO2 하에서 24시간 배양하였다. 여기에 각 농도의 시료를 2㎕씩 첨가하여 48시간 동안 다시 배양한 후 MTT(0.5mg/mL)용액을 각각 첨가하여 MTT가 생존 암세포의 효소작용에 의해 환원되도록 하였다. 4시간 후 well 바닥에 형성된 포마즌(formazan)이 흩어지지 않게 조심스럽게 다루어 흡입기(aspirator)로 상층액을 제거하였다. 각 well에 DMSO 200㎕를 첨가하여 포마즌이 용해되도록 한 후 측정기(microplate reader)로 O.D. 540㎚에서 흡광도를 측정하였다. MTT measurements of cell proliferation and toxicity were examined for the effect of jujube seed extract on cancer and normal cell growth. Inhibitory effect of jujube seed extract on hepatocellular carcinoma Hep G2 (hepatoma cell, human) and colon cancer cell HT-29 (colon carcinoma cell, human), hematological cancer U937, promyelocytic leukocyte HL60 and human Confirmed. First, remove the medium from the cultured cells, mix lightly with the addition of the buffer solution, remove the buffer again, incubate for 5 minutes at 37 ° C by adding 0.25% trypsin-EDTA, and check whether the cells were completely separated from the bottom of the culture dish. After observation, the culture medium was added and mixed well, and then the cell number was adjusted to 1 × 10 5 cells / mL. Samples were dissolved in DMSO (dimethysulfoxide) at appropriate concentrations and filtered through a 0.22 μm membrane filter. Each cell prepared in a 96-well plate was dispensed 198 μl and incubated for 24 hours at 37 ℃, 5% CO2. 2 μl of each concentration sample was added thereto, followed by incubation for 48 hours, and then MTT (0.5 mg / mL) solution was added to reduce MTT by enzymatic action of viable cancer cells. After 4 hours, the supernatant was removed by an aspirator by carefully treating the forazan formed on the bottom of the well to prevent scattering. 200 μl of DMSO was added to each well to dissolve the formazon, and then the O.D. Absorbance was measured at 540 nm.
실험결과, 표 4 내지 6에 나타낸 바와 같다. 간암세포인 HepG2에서 각각 1mg/mL, 0.5mg/mL의 농도에서 56.3%, 58%의 억제효과를 나타내었으며, 결장암세포인 HT29에서는 1mg/mL, 0.5mg/mL의 농도에서 71.3%, 66.7%의 높은 억제효과를 나타 내었다. 사람의 혈액암세포 U937에서 각각 1mg/mL, 0.5mg/mL의 농도에서 70.1%, 70.7%의 높은 억제효과를 나타내었으며, 전골수백혈구세포 HL60에서 각각 1mg/mL, 0.5mg/mL의 농도에서 59.5%, 58.3%의 억제효과를 나타내었다. 또한 사람의 정상 간세포인 Chang에서는 각각 1mg/mL, 0.5mg/mL의 농도에서 15.5%, 16.9%의 세포 증식 효과를 나타내었다. 이 결과로 대추씨 추출물이 암세포에 대해 성장 억제 효과가 있으며 정상 간세포에는 세포 증식 효과를 확인하였다.The experimental results are as shown in Tables 4 to 6. HepG2, a hepatocarcinoma cell, showed 56.3% and 58% of inhibitory effect at 1mg / mL and 0.5mg / mL, respectively, and HT29, a colon cancer cell, at 7mg% and 66.7% at 0.5mg / mL, respectively. Showed a high inhibitory effect. In human blood cancer cell U937, the inhibitory effect was 70.1% and 70.7% at the concentration of 1mg / mL and 0.5mg / mL, respectively, and 59.5 at the concentration of 1mg / mL and 0.5mg / mL, respectively, in the proliferation of HL60. %, 58.3% showed an inhibitory effect. Chang, a normal human hepatocyte, showed cell proliferation effects of 15.5% and 16.9% at concentrations of 1 mg / mL and 0.5 mg / mL, respectively. As a result, jujube seed extract had a growth inhibitory effect on cancer cells and a cell proliferation effect on normal hepatocytes.
<표 4> 대추씨 물 추출물의 간암세포와 결장암세포에 대한 억제효과Table 4 Inhibitory Effects of Jujube Seed Water Extracts on Hepatocellular Carcinoma and Colon Cancer Cells
<표 5> 대추씨 물 추출물의 혈액암세포, 전골수백혈구세포에 대한 억제효과<Table 5> Inhibitory Effects of Jujube Seed Water Extracts on Hematological Cancer Cells and Promyelocytic Leukocytes
<표 6> 대추씨 물 추출물의 정상 간세포의 성장에 미치는 영향<Table 6> Effect of Jujube Seed Water Extract on the Growth of Normal Hepatocytes
이상의 실시예 및 실험예를 통하여 설명한 바와 같이, 본 발명은 대추씨에서 90~100℃의 열수추출한 물 추출물 또는 시료의 10배의 99% 메탄올을 이용한 메탄올 추출물이 항산화 소거 효과와 항변이원성 직접변이원인 유기체 메틸화학제와 나이트로놀린옥사이드에 대하여 돌연변이 억제에 뛰어난 효과가 있다. As described in the above Examples and Experimental Examples, the present invention is a water extract extracted from 90 ~ 100 ℃ in jujube or methanol extract using 10 times 99% methanol of the sample is the antioxidant scavenging effect and anti-mutagenic direct mutagens It has an excellent effect on the inhibition of mutations against the organism methyl chemical agent and nitronoline oxide.
또한, 본 발명은 대추씨 물 추출물이 사람의 간암 세포, 결장암세포, 혈액암세포 및 전골수백혈구세포 증식 억제와 정상 간세포 증식 효과를 나타내므로, 이는 기능성 식품제조 및 의약 산업상 매우 유용한 발명인 것이다.In addition, the present invention, since jujube seed water extract exhibits the effect of inhibiting the proliferation of human liver cancer cells, colon cancer cells, blood cancer cells and promyelocytic leukocytes and normal hepatocyte proliferation, it is a very useful invention for functional food manufacturing and pharmaceutical industry.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060070374A KR100801902B1 (en) | 2006-07-26 | 2006-07-26 | Composion for antimutagenic and anticancer containing the extracts of Zizyphus jujube seed |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060070374A KR100801902B1 (en) | 2006-07-26 | 2006-07-26 | Composion for antimutagenic and anticancer containing the extracts of Zizyphus jujube seed |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080010193A KR20080010193A (en) | 2008-01-30 |
KR100801902B1 true KR100801902B1 (en) | 2008-02-12 |
Family
ID=39222370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060070374A KR100801902B1 (en) | 2006-07-26 | 2006-07-26 | Composion for antimutagenic and anticancer containing the extracts of Zizyphus jujube seed |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100801902B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040116394A1 (en) * | 2002-12-13 | 2004-06-17 | Dabur Research Foundation | Method for treating cancer using betulinic acid rich herbal extract |
KR100583051B1 (en) * | 2003-12-31 | 2006-05-24 | 한국생명공학연구원 | Extracts of cinnamon and zizyphus zuzuba for the prevention and treatment of cancers |
-
2006
- 2006-07-26 KR KR1020060070374A patent/KR100801902B1/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040116394A1 (en) * | 2002-12-13 | 2004-06-17 | Dabur Research Foundation | Method for treating cancer using betulinic acid rich herbal extract |
KR100583051B1 (en) * | 2003-12-31 | 2006-05-24 | 한국생명공학연구원 | Extracts of cinnamon and zizyphus zuzuba for the prevention and treatment of cancers |
Also Published As
Publication number | Publication date |
---|---|
KR20080010193A (en) | 2008-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jain et al. | Crude tea extracts decrease the mutagenic activity of N-methyl-N′-nitro-N-nitrosoguanidine in vitro and in intragastric tract of rats | |
KR101324926B1 (en) | Manufacturing Mathod of Ginger Extract And Ginger Extract Using The Same | |
Wang et al. | Cytotoxic effects of chlorophyllides in ethanol crude extracts from plant leaves | |
Zavastin et al. | Studies on antioxidant, antihyperglycemic and antimicrobial effects of edible mushrooms Boletus edulis and Cantharellus cibarius. | |
Tian et al. | Phytochemical composition and antioxidant capacity of Cordia dichotoma seeds. | |
Basgedik et al. | Antimicrobial, antioxidant and antimutagenic properties of Iris albicans | |
KR20150050726A (en) | fermented red ginseng concentrate having hepatoprotective activity and manufacturing method thereof | |
KR101209574B1 (en) | Pharmaceutical compositions and health functional foods compositions for the improvement of liver functions containing compound isolated from Youngia denticulata as an active ingredient | |
Shahrani et al. | Astragalus fasciculifolius manna; antinociceptive, antiinflammatoryand antioxidant properties in mice | |
KR100801902B1 (en) | Composion for antimutagenic and anticancer containing the extracts of Zizyphus jujube seed | |
JP2004059566A (en) | Natural antibacterial agent | |
Zhang et al. | Antioxidant, anti-inflammatory and cytotoxicity on human lung epithelial A549 cells of Jerusalem artichoke (Helianthus tuberosus L.) tuber | |
KR20140108796A (en) | Drug composition containing extract of Juncus Effusus L. for anti-oxidative and anti-tumor activity | |
KR101070382B1 (en) | Soap containing the extracts of Zizyphus jujube seed and manufacturing method of it | |
KR100462788B1 (en) | Composition containing an extract of pericarpium zanthoxyli for protecting brain cells and improving memory | |
KR101790654B1 (en) | Extraction of polysaccharides from pine nut cake and composition comprising pine nut extract for preventing or treating liver cancer | |
Peng et al. | Evaluation of in vitro antioxidant and antitumour activities of Astragalus membranaceus aqueous extract | |
KR101798205B1 (en) | Food composition increased gamma-aminobutyric acid comprising fermentated barley leaf and corn silk as active ingredient | |
KR20120066794A (en) | Urushiol reduction disposed lacquer, lacquer extract by using the same and method of manufacturing the same | |
KR100458300B1 (en) | Drink Composition Containing Extracts of Gastrodia elata Blum | |
KR20060007104A (en) | Organic constituents of wood vinegar from konara having the effects of cure and prevention of cancer, antibacterial and antioxidant | |
Namdeo et al. | Antioxidant activity of methanolic extracts of Nothapodytes nimmoniana (J. Graham) Mabberly | |
Chaiyasut et al. | Development and quality assessment of Lactobacillus paracasei HII01 mediated fermented Kaempferia parviflora wall. Ex. Baker juice | |
KR20200000743A (en) | A composition for improving diabetes or for use of antioxidant comprising yeast extract and a method for preparing the yeast extract | |
KR20180136592A (en) | Composition for anticancer containing extract of Jeju camellia mistletoe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130801 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140204 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |